Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer

Published:2018-11 Issue:5 Volume:106 Page:1533-1540
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Mulvihill Michael S.,Cox Morgan L.,Becerra David C.,Watson Joshua A.,Voigt Soraya L.,Yerokun Babatunde A.,Speicher Paul J.,D’Amico Thomas A.,Tong Betty,Hartwig Matthew G.

Funder

National Institutes of Health

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference21 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. National Comprehensive Cancer Network. 2017 NCCN clinical practice guidelines in oncology: non-small cell lung cancer. Available at www.nccn.org. Accessed December 29, 2017.

3. American College of Chest Physicians. Methodology for lung cancer evidence review and guideline development: ACCP evidence-based clinical practice guidelines (2nd edition);McCrory;Chest,2007

4. Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer;Gray;Cancer,2012

5. Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010;Kaniski;Lung Cancer,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Ward Noise Reduction Administration on Mental Health and Lung Function of Patients with Lung Cancer;Noise and Health;2024-04

2. European Respiratory Society guideline on various aspects of quality in lung cancer care;European Respiratory Journal;2022-11-17

3. Travelling to a High-Volume Center Confers Improved Survival in Stage I Non-small Cell Lung Cancer;The Annals of Thoracic Surgery;2022-02

4. Chirurgische Therapie im Stadium I und II des nichtkleinzelligen Lungenkarzinoms;Der Onkologe;2018-10-15